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Abstract
Background: ATP-binding cassette (ABC) transporters are essential regulators of organismic homeostasis, and are
particularly important in protecting the body from potentially harmful exogenous substances. Recently, an increasing
number of in vitro observations have indicated a functional role of ABC transporters in the differentiation and maintenance
of stem cells. Therefore, we sought to determine brain-related phenotypic changes in animals lacking the expression of
distinct ABC transporters (ABCB1, ABCG2 or ABCC1).
Methodology and Principal Findings: Analyzing adult neurogenesis in ABC transporter-deficient animals in vivo and
neuronal stem/progenitor cells in vitro resulted in complex findings. In vivo, the differentiation of neuronal progenitors was
hindered in ABC transporter-deficient mice (ABCB1
0/0) as evidenced by lowered numbers of doublecortin
+ (236%) and
calretinin
+ (237%) cells. In vitro, we confirmed that this finding is not connected to the functional loss of single neural stem/
progenitor cells (NSPCs). Furthermore, assessment of activity, exploratory behavior, and anxiety levels revealed behavioral
alterations in ABCB1
0/0 and ABCC1
0/0 mice, whereas ABCG2
0/0 mice were mostly unaffected.
Conclusion and Significance: Our data show that single ABC transporter-deficiency does not necessarily impair neuronal
progenitor homeostasis on the single NSPC level, as suggested by previous studies. However, loss of distinct ABC
transporters impacts global brain homeostasis with far ranging consequences, leading to impaired neurogenic functions in
vivo and even to distinct behavioral phenotypes. In addition to the known role of ABC transporters in proteopathies such as
Parkinson’s disease and Alzheimer’s disease, our data highlight the importance of understanding the general function of
ABC transporters for the brain’s homeostasis and the regeneration potential.
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Introduction
ABC transporters arise from one of the largest known
superfamily of genes, and can be found in every living organism.
Most ABC transporters carry out unidirectional transmembrane
transport [1]. Functionally, ABC transporters can be separated
into three groups: i) importers, mostly used to import nutritious
molecules and ions in prokaryotes [2,3], ii) exporters, which secrete
a broad variety of dietary cytotoxic agents and thereby also
numerous therapeutic drugs across biological membranes (re-
viewed in [4]), and iii) a subgroup that is involved in chromatin
reorganization, DNA repair, telomere maintenance and RNA
trafficking [5,6,7]. Currently, 49 different human ABC genes have
been identified in humans, and these are classified into seven
subgroups named ABCA to ABCG based on amino acid
sequence-similarities and phylogeny (reviewed in [8,9]). ABC
transporters are capable of transporting a wide range of peptides,
hydrophobic molecules, drugs or drug conjugates. Together, they
form a chemo-defense network against xenobiotics [10]. Recently,
ABC transporters have been discovered to exhibit important
export functions for proteins involved in Alzheimer’s disease
[11,12], with ABCC1 being of exceptional importance for the
clearance of b-amyloid from the brain [13]. In addition to their
role as crucial components of barriers that protect the brain from
toxic substances, such as the blood-brain barrier (BBB) and the
blood-cerebrospinal fluid barrier (reviewed in [12,14]), these
molecules also are expressed on stem cells of various tissues, and
were discovered in cancer cells.
Accordingly, p-glycoprotein, later identified as ABCB1, was first
found to maintain cell surface permeability in a hamster cell line
[15], and was later linked to chemoresistance in a multidrug
resistant Chinese hamster ovary cell line [16]. Later, ABCG2 was
isolated from multidrug-resistant breast cancer cells in the absence
of ABCB1 [17], while ABCC1 was found to be highly expressed in
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to the fact that many cancer cells manifest a stem cell- or
progenitor-like gene expression pattern [19], it was not surprising
that ABC transporter expression has been detected in a variety of
organ-specific stem cells throughout the organism (reviewed in
[20]). Hematopoietic stem cells show a reduced staining profile for
the mitochondrial marker Rhodamine 123, which is a substrate of
ABCB1, indicating high expression levels of ABCB1 in these stem
cells [21]. Using fluorescence-activated cell sorters and bone
marrow cells stained with fluorescent dyes such as Rhodamine 123
and Hoechst 33342, a small, low-profile subset of cells with
phenotypic markers of hematopoietic stem cells was revealed [22].
This population is lost in the Hoechst profile after administration
of the ABCB1 inhibitor verapamil [22,23], and was later
confirmed in non-hematopoietic cell populations such as pancre-
atic mesenchymal stem cells [24]. Mice lacking ABCB1 or ABCG2
do not show altered phenotypes [25,26] except for higher brain
concentrations of ABCB1-transported agents/ligands, an in-
creased immunological response to normal bacterial flora
(ABCB1
0/0) [27], and a distinct form of dietary-induced proto-
porphyria (ABCG2
0/0) [28]; however, these studies did not
investigate neurogenic or cognitive functions.
Recently, in vitro studies showed high expression rates of ABCB1
[29] and ABCG2 [30] in neurospheres during proliferation. The
expression of both ABC transporters decreased substantially with
the advancing state of differentiation, again suggesting a functional
involvement of ABC transporters in stem cell homeostasis [31].
Considering the increasing number of observations indicating
a functional role of ABC transporters in stem cell maintenance and
differentiation, mostly from in vitro studies, we hypothesized that
neurogenic processes would be impaired due to the deficiency of
distinct ABC transporters. We focused on the transporters ABCB1
(MDR1, subfamily B) and ABCG2 (BCRP, subfamily G) based on
the studies of Islam and colleagues [29,30], who first observed the
transient expression of ABC transporters in NSPCs. Furthermore,
we chose ABCC1- (MRP1, subfamily C) deficient mice because
little information is available about its function in neurogenic
processes, and because we recently showed its potential signifi-
cance for brain homeostasis in proteopathies such as Alzheimer’s
disease [17]. In the present study, we focused on the assessment of
possible impairments of neurogenesis and cognitive alterations in
vivo and cell-intrinsic effects on NSPC functions in vitro with regard
to deficiency for the distinct ABC transporters.
After comparative analyses of ABC transporter-deficient mouse
strains and tissue in vivo and in vitro, we can confirm that
a deficiency of ABC transporters leads to distinct impairments in
NSPC maturation and adult neurogenesis in vivo. However, the in
vitro experiments to determine proliferation and differentiation
changes of NSPCs revealed that the underlying processes are not
related to single stem cells. Consistent with the neurogenic
alterations, we also show that ABC transporter-deficiency leads
to far-ranging functional changes, even resulting in distinct
behavioral phenotypes in a set of basic behavioral tests.
Results
ABC transporter-deficiency affects neuronal
differentiation of NSPCs
To assess the influence of ABC transporter-deficiency on
neurogenesis, we analyzed molecular markers of neurogenic
progenitors or immature neurons in the subgranular zone (SGZ)
of the dentate gyrus (DG) in adult mice aged 3–4 months. We
characterized marker proteins to quantify the differentiation states
of NSPCs. To label very early stem and progenitor cells, we used
an antibody against Sox2, a transcription factor that is required for
maintenance of stem cell status, and therefore a reliable marker of
early undifferentiated NSPCs [32,33,34]. To quantify the number
of early neuronal progenitors, we used the marker protein
doublecortin (DCX) [35,36]. Postmitotic, newly generated neu-
rons at a stage of axonal and dendritic targeting were labeled with
an anti-calretinin antibody [37]. The quantification of the cells
revealed a significant increase in Sox2
+ early NSPCs only in
ABCC1
0/0 (+17%) mice, whereas their number was not altered in
ABCB1
0/0 or in ABCG2
0/0 mice as compared to the genetic
background controls (FVB/N) (Figure 1A). Investigating early
neuronal progenitors, which are positive for DCX, revealed
a significant decrease of these cells in mice lacking ABCB1 (236%)
or ABCG2 (223%), but no changes in ABCC1
0/0 mice
(Figure 1B). Quantifying the number of post-mitotic, newly
generated calretinin
+ neurons, we also detected decreased cell
numbers in ABCB1
0/0 animals (237%), while deficiency in
ABCG2 or ABCC1 did not induce significant effects (Figure 1C).
The proliferation capacity (BrdU
+ cells) was not affected in any of
the analyzed ABC transporter-deficient mice (Figure 1D). Thus,
ABCC1
0/0 mice only revealed slightly increased numbers of early
NSPCs, while the fate of differentiation was not affected.
ABC transporter-deficiency alters the rate of NSPC
differentiation
To analyze Sox2, DCX and calretinin expression in the actively
proliferating NSPC population, we double-labeled brain sections
for BrdU and the respective marker protein. The mice received
BrdU for 7 days prior to sacrifice. The analyses revealed
decreasing amounts of newly proliferating Sox2
+ NSPCs in the
absence of each of the three ABC transporters (225% ABCB1
0/0;
228% ABCG2
0/0; 237% ABCC1
0/0; Figure 2A, 2D). The
number of DCX
+ neuronal progenitors did not show any ABC
transporter-related changes in the proliferating population
(Figure 2B, 2E). Interestingly, the population of post-mitotic,
newly differentiated granule cells expressing calretinin significantly
increased both in ABCG2
0/0 (+43%) and ABCC1
0/0 (+51%) mice,
while the increase in ABCB1
0/0 mice did not reach statistical
significance (Figure 2C, 2F).
ABC transporter deficiency does not impair neurogenic
functions in vitro
To analyze the proliferation capacity of ABC transporter-
deficient NSPCs, we used primary NSPC lines from the
subventricular zone of control and ABC transporter-deficient
animals. The proliferation capacity of NSPCs was measured by
BrdU-uptake into the DNA of proliferating cells, and compara-
tively quantifying the BrdU
+ cell fraction of each cell line. The
BrdU intake over a period of 30 min revealed a significant
increase in proliferation activity in cell lines deficient in the ABC
transporter ABCG2 (+62%) (Figure 3A, 3B). The increase of
proliferation activity in ABCB1
0/0 and ABCC1
0/0 cells did not
reach significance.
To assess the differentiation potential of these primary NSPC
lines, we let the cells differentiate for 3 days and quantified the
number of differentiated neurons using immunofluorescence
techniques. Comparing the fraction of Tuj1
+, newly differentiated
neurons among the different NSPC lines, we could not detect
significant alterations (Figure 3C, 3D). Therefore we conclude that
deficiency of ABCB1, ABCG2 or ABCC1 does not affect the
ability of NSPCs to differentiate into neurons per se.
ABC Transporters in Neurogenesis
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To confirm whether ABC transporters are expressed in pro-
liferating NSPCs, we used TaqManH assays to quantify relative
expression levels for ABCB1a, ABCB1b, ABCG2 and ABCC1 in
background controls and ABC transporter knockout strains.
Quantitative RT-PCR analyses with NSPC mRNA confirmed that
all three transporters (B1, C1, G2) are expressed, and also indicated
a possible co-regulation between ABCB1 and ABCG2. We found
only one form (ABCB1b) of the murine ABCB1 transporter
expressed in NSPCs, while ABCB1a mRNA was not detectable.
Analyses showed that the lack of ABCG2 led also to a significant
decrease of ABCB1 mRNA amounts (228%) (Figure 4A). In
contrast, loss of ABCB1b expression led to a marked increase in
ABCG2mRNA(+71%)(Figure4B).WealsofoundABCG2mRNA
levels increased by 73% as a result of ABCC1 deficiency, although
thisincreasedidnotreachstatisticalsignificance(Figure4B).Onthe
other hand, ABCC1 deficiency did not lead to significant effects on
the expression ofABCB1or ABCG2.However, ABCC1expression
itself seemed not to be altered by the loss of neither ABCB1 nor
ABCG2 expression (Figure 4C).
ABC transporter-deficiency reduces neurogenesis in
disease states
Traumatic brain injury is known to activate the proliferation
and differentiation of resident NSPCs [38]. Since ABC trans-
porter-deficiency under normal physiologic conditions causes only
minor phenotypic changes, we wanted to assess the potential
importance of the transporters during disease states. The
controlled cortical impact (CCI) paradigm [39] was chosen to
amplify minor effects of ABC transporter involvement in NSPC
homeostasis with regard to proliferation and differentiation
capacity. Therefore, cortical trauma was induced 7 days prior to
analysis. In agreement with recent publications [38,39,40],
neurogenic processes were significantly increased in the dentate
gyrus of the induced (injured) hemisphere compared to the
contralateral control hemisphere in all analyzed strains (Figure 5).
CCI-induced trauma resulted in a highly increased cell
proliferation in the SGZ of the affected hemisphere in all analyzed
mouse strains. The proliferation index of the ipsilateral hemi-
spheres was significantly increased as compared to the contralat-
eral, untreated control hemispheres in all mice. Importantly, ABC
transporter deficiency substantially altered the extent of the
proliferation increase. Relative to the control group, we observed
significantly lower ipsilateral proliferation indices in all three ABC
transporter-deficient strains (247% ABCB1
0/0; 231% ABCG2
0/
0; 253% ABCC1
0/0, Figure 6A). Consistent with the highly
increased cell proliferation, we also detected an expansion in the
analyzed subpopulations after CCI-treatment. CCI led to in-
creased numbers of Sox2
+ NSPCs in the ipsilateral hemisphere
independent of ABC transporter expression (Figure 6B). However,
the CCI paradigm mostly affects the number of differentiating cells
of the neuronal lineage that are DCX
+ and calretinin
+. All mice
showed significantly more differentiating DCX
+ neuronal pro-
genitors in the induced hemisphere as compared to the control
hemispheres. Comparing controls and ABC transporter-deficient
strains, only ABCB1
0/0 and ABCC1
0/0 mice exhibited a sub-
stantial decrease in the number of differentiating DCX
+ neuronal
progenitors (236% ABCB1
0/0; 233% ABCC1
0/0), while the cell
number was not affected in ABCG2
0/0 mice (Figure 6C).
Analogous to the situation of the DCX
+ cell pool, we also
detected significantly lower numbers of calretinin
+ postmitotic
Figure 1. Deficiency of ABCB1 impairs neuronal differentiation in the SGZ of the dentate gyrus. Shown are the relative quantities of cells
positive for Sox2, DCX, calretinin and BrdU in the SGZ of the dentate gyrus in ABC transporter-deficient mice as compared to the FVB controls. A)
Sox2
+ NSPCs increased significantly in ABCC1 transporter-deficient mice (+17%), while ABCB1- or ABCG2-deficient mice were unaffected. B) Early
DCX
+ neurons were significantly decreased in the absence of ABCB1 (236%) and ABCG2 (223%), while later, post-mitotic calretinin
+ cells (C) were
only reduced in ABCB1 transporter-deficient mice by 37%. D) The proliferation capacity (BrdU
+ cells) was not affected in any of the analyzed ABC
transporter-deficient mice. Error bar: SEM; * p,0.05; **p,0.01.
doi:10.1371/journal.pone.0035613.g001
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0/0 and ABCC1
0/
0 mice (229% ABCB1
0/0; 224 ABCC1
0/0) (Figure 6D).
Comparing the different strains, we saw only a slight, non-
significant decrease of Sox2
+ progenitors in ABC transporter-
deficient mice as compared to controls, indicating that the lack of
ABCB1 or ABCC1 significantly reduces the number of cells
differentiating into a neuronal lineage. The numbers of both
DCX
+ and calretinin
+ cells were significantly lower in ABCB1-
and ABCC1-deficient mice, while there was no difference
observable in animals lacking the transporter ABCG2. The only
parameter that was consistently affected in all three ABC
transporter-deficient strains was the proliferation capacity.
ABC transporter-deficiency does not affect neuronal area
in the neocortex
The above analyses indicate that ABC transporter-deficiency
differentially influences neurogenic function in the hippocampal
subgranular zone. Thus, we wanted to determine whether these
differencesalsoinfluencethedensityofneuronsintheneocortex.To
assessneuronalareainthecerebralcortex,weestablishedareviewer-
independent method to determine the total area covered by NeuN
+
cellsinanormalizedcorticalarea.Paraffin-embeddedbrainsections
were cut and immunohistochemically stained for the neuronal
marker NeuN. Brain sections were digitized at a resolution of
230 nm/pixel, and the NeuN
+ areas were discriminated from
unstained cortex [41] to determine the NeuN
+ fraction of the
cortical area (Figure 7B). Comparison of the neuronal densities did
not reveal significant differences between the ABC transporter-
deficient strains and genetic background controls.
ABC transporter-deficiency effects cortical
cytoarchitecture
To assess whether loss of ABC transporter function possibly
results in deficits in cortical development, which might be reflected
Figure 2. ABCC1 deficiency impairs stem cell proliferation and accelerates late neuronal differentiation. The graphs show the newly
generated population (BrdU incorporation) of Sox2
+ (A), DCX
+ (B) and calretinin
+ (C) cells in the SGZ of the DG. The number of proliferating Sox2
+
NSPCs was significantly decreased in ABCB1- (225%), ABCG2- (228%) and ABCC1- (237%) deficient mice, implicating slower proliferation of NSPCs
within the 7 days of BrdU treatment. In contrast, late neuronal differentiation seems to be accelerated due to the significantly greater proportion of
BrdU
+ postmitotic early granule cells expressing calretinin in animals lacking ABCG2 (+43%) and ABCC1 (+51%) expression. The photomicrographs
display expression examples for marker combinations: Sox2/BrdU (D), DCX/BrdU (E) and calretinin/BrdU (F). Arrowheads indicate double-labeled cells.
Error bar: SEM; * p,0.05; **p,0.01; Scale bar: 20 mm.
doi:10.1371/journal.pone.0035613.g002
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cortical layers I-VI. The NeuN-stained paraffin slices were
measured according to Manuel and colleagues [42] for layer
thickness (Figure 7A). By comparing the proportional size of layer
I, II–IV (combined), V and VI, we found significant effects of
deficient ABC transporter expression on cortical architecture in
ABCB1
0/0 and ABCC1
0/0 strains. The loss of ABCB1 resulted in
a decreased size (212%) of layer I (Figure 7C), while all other
layers were unaffected. The other significant effect showed
ABCC1
0/0 mice where only the size of layer VI was increased
by 15% (Figure 7C). ABCG2
0/0 animals showed no significant
alterations in the cortical architecture. Layers I and VI represent
the least cellular layers of the cortex with mostly interconnecting
dendrites and axons.
ABC transporter-deficiency influences activity and
anxiety levels
Because the hippocampus functions as a main interface between
different cortical inputs and is important for memory consolida-
tion, we wanted to determine whether the absence of specific ABC
transporters results in behavioral changes. To assess potential
alterations in overall activity, exploratory behavior, or the level of
anxiety, we used Y- and elevated plus mazes as well as the light/
dark box setup [43,44,45,46]. First, the animals were analyzed for
Figure 3. ABC transporter-deficiency did not lead to impairments of neuronal differentiation in vitro. ABCG2
0/0 cells showed a significant
increase in proliferation capacity (+62%, A) quantified by detection of BrdU uptake using immunofluorescence (B). The differentiation capacity was
not impaired by loss of ABC expression (C) as revealed by quantification of neuronal cells positive for Tuj1 (D). Error bar: SEM; Scale bar: 50 mm.
doi:10.1371/journal.pone.0035613.g003
Figure 4. Expression of ABCB1b and ABCG2 are co-regulated in NSPCs in vitro. Relative mRNA expression of ABCB1b, ABCG2 and ABCC1
was measured against mRNA expression of GAPDH using TaqManH assays. Expression of ABCB1b was significantly impaired (228%) in ABCG2
0/0 cells
(A). In reverse, expression of ABCG2 was increased significantly (+71%) in animals lacking ABCB1 expression, while a comparable effect on ABCC1
0/
0 cells did not reach statistical significance (B). For ABCC1 mRNA expression, no significant changes were observed in the other cell lines (C). Error bar:
SEM; * p,0.05; **p,0.01.
doi:10.1371/journal.pone.0035613.g004
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behavior using the Y-maze. We did not detect significant effects of
transporter deficiency on alternation behavior, but the activity of
ABCB1
0/0 or ABCC1
0/0 mice was significantly reduced as
detected by the shortened running distance (Figure 8A) and
reduced number of arm entries (Figure 8B). Specifically, ABCB1
deficiency led to a 13% decrease in the running distance and
a 16% decrease in arm entries, and these effects were even more
pronounced in ABCC1-deficient mice (running activity 217%,
arm entries 223%).
The elevated plus maze was used to assess anxiety levels in the
mice. The basic principle of this maze is that the exploratory drive
is equal for each arm, while the anxiety-driven aversion to
enclosed arms is lower than to open arms, resulting in an increased
exploration of the enclosed arms [47]. Analyzing the time spent in
the open arms revealed a significant decrease in ABCB1
0/0 or
ABCG2
0/0 mice (244% ABCB1
0/0; 231% ABCG2
0/0) (Fig-
ure 9A), while the decline did not reach statistical significance in
ABCC1
0/0 mice. All transporter deficient mice remained longer in
the enclosed compartments of the maze (+43% ABCB1
0/0, +24%
ABCG2
0/0, +32% ABCC1
0/0) (Figure 9B). Regarding the running
velocity in the open compartment, we could not find any
significant alterations (Figure 9C). In contrast, a significant
reduction in running speed within the enclosed compartments
was measured in ABCB1
0/0 and ABCC1
0/0 mice (223%
ABCB1
0/0; 214% ABCC1
0/0), but not in ABCG2
0/0 mice
(Figure 9D).
The light/dark box experiments allowed us to assess the overall
exploratory behavior as in an open-field test (running distance,
rearing, transitions) as well as anxiety like behavior (light
avoidance, differing activity under light and dark). Comparing
the distances travelled by mice within the open compartment of
the maze, no significant alterations were observed with regard to
ABC transporter-deficiency (Figure 10A). However, mice deficient
for ABCB1 showed increased activity within the dark compart-
ment of the maze (Figure 10B), as indicated by increased running
distance (+64%). This finding is consistent with the significantly
increased proportion of time spent in the dark compartment
compared to controls (Figure 10C). A lower number of transitions
between the two compartments showed impairments in explor-
atory behavior of both ABCB1 and ABCC1 transporter-deficient
animals. The number of transitions was significantly decreased by
59% (ABCB1
0/0) and 49% (ABCC1
0/0) compared to controls
(Figure 10D). Rearing activity was differentially altered within the
different maze compartments. While ABCC1-deficient mice
showed significantly decreased rearing activity in the open-field
compartment (267%; Figure 10E) and no difference in the dark
compartment (Figure 10F), mice lacking ABCB1 did not show
alterations in rearing activity in the open field (Figure 10E), but
increased activity in the dark compartment (+71%; Figure 10F).
Discussion
ABC transporter function has been proposed to influence
hematopoietic and neuronal stem cell proliferation and differen-
tiation in vitro [31]. Here, we demonstrate for the first time that the
loss of ABC transporter function also leads to specific impairments
in neurogenesis and neurofunctional changes in vivo. We show that
the deficiency of the ABC transporter ABCB1 significantly affects
stem cell homeostasis in vivo, while these effects do not appear to be
based upon cell-intrinsic effects due to unaffected NSPC
differentiation in vitro. Furthermore, we were able to determine
that the lack of ABCC1, a transporter not yet recognized in the
setting of NSPC functions, leads to a significant decline in the
neurogenic differentiation of NSPCs during disease states such as
traumatic brain injury. With regard to cognitive functions, we
found that ABC transporter status influences the levels of overall
activity and anxiety.
Recent in vitro studies revealed ABCB1 and ABCG2 expression
in proliferating neuronal progenitors. The expression disappeared
during differentiation, thus suggesting a role of the transporters in
maintaining the cells in a specified state [29,30,48]. With this in
mind, we sought to find quantitative impairments in the neuronal
stem and progenitor cell pool. However, ABC transporter-
deficiency did not significantly alter the Sox2
+ NSPC pool.
Rather, the absence of ABCB1 impaired the differentiation of
NSPCs into the neuronal lineage, as detected by significantly
decreased amounts of DCX
+ and calretinin
+ cells. Although
ABCG2 was found to be expressed in NSPCs [30], in our analysis,
its deficiency only slightly altered neurogenic functions in ABCG2-
deficient mice in vivo. Analyzing the BrdU
+ fraction of Sox2
+ cells,
we found impaired proliferation in the ABC transporter-deficient
mice. For ABCG2
0/0 and ABCC1
0/0 mice, the BrdU
+ fraction of
calretinin
+ cells increased significantly. Therefore, it is likely that
NSPCs lacking one of the analyzed ABC transporters experience
a higher turnover because they are not able to stabilize their stem
cell character, thus supporting the view that ABC transporters are
involved in NSPC homeostasis.
The impairment of neurogenic differentiation in ABCC1
transporter-deficient mice was disclosed using an induction model
in which the brain was stressed by acute traumatic injury. Thus,
disease states demanding increased regeneration potential help to
uncover functions of ABC transporters beyond their known roles
in normal cell physiology. Indeed, such disease-related functions
Figure 5. Neurogenesis is induced by controlled cortical impact
(CCI) trauma. The photomicrographs show the SGZ of the DG after
CCI (LEFT: Control hemispheres; RIGHT: hemispheres after CCI). Shown
are the marker combinations Sox2/BrdU (A), DCX/BrdU (B) and
calretinin/BrdU (C). Arrowheads indicate double labeled cells. Scale
bar: 20 mm.
doi:10.1371/journal.pone.0035613.g005
ABC Transporters in Neurogenesis
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35613Figure 6. ABC transporters are important for neurogenic functions during disease states as revealed by the CCI paradigm. The
proliferation capacity measured by BrdU incorporation (A) was significantly decreased in the induced hemisphere of all ABC transporter-deficient
strains (ABCB1
0/0: 247%; ABCG2
0/0: 231%; ABCC1
0/0: 253%) (right). The number of Sox2
+ cells was not significantly altered in the induced brain
hemisphere (B), but shows a trend toward a decreased number in ABCB1- and ABCC1- deficient mice that resembles the decreases in immature DCX
+
and calretinin
+ neurons (C, D). The number of DCX
+ neuronal progenitors (B) was significantly reduced in the induced hemisphere of ABCB1- (236%)
or ABCC1-deficient (233%) animals as compared to controls (right). Additionally, the number of early granule cells expressing calretinin (D) was
decreased in the induced hemisphere of ABCB1- (29%) and ABCC1-deficient mice (224%) (right), while there was no change in ABCG2-deficient mice.
Error bars: SEM, *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0035613.g006
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erative diseases, stroke or the effects of brain aging. With regard to
aging, it is important to consider the physiological function of ABC
transporters not only at barriers and epithelia, but also in the
brain’s NSPC pool. The ABC transporters convey a wide
spectrum of biological and metabolic substrates [2,3,4].
The impairment of ABC-mediated excretion across the BBB
might alter the microenvironment of the stem cell niche, which is
located directly between the vascular and the ventricular system.
The interaction of the NSPCs with both systems thereby implies
changes in the NSPC’s homeostasis due to altered ABC transport
[49]. In the absence of sufficient ABC transport, metabolites and
chemical compounds can reach functional and/or pathogenic
concentrations within the cells, and thus influence the NSPC pool
or its differentiation behavior. For instance, it has been shown that
endothelial cells are able to generate soluble factors that can
influence the differentiation of NSPCs in vitro [50]. Assuming that
some of these factors are substrates for ABC transporters, their
diminished elimination by transporters could adversely influence
both the microenvironment of the stem cell niche and cellular
homeostasis, thereby altering NSPC functions.
Our investigations of the proliferation capacity and ability to
differentiate into neuronal lineage in vitro did not support the idea
of a cell-intrinsic function of any of these ABC transporters,
directly influencing the cell fate [29,30,31]. While we found that
NSPCs appear to benefit from the absence of ABCG2 expression,
as evidenced by higher cell proliferation, our differentiation
experiments did not reveal any impairment due to ABC
transporter-deficiency. In particular, the increased proliferation
capacity of NSPCs lacking ABCG2 expression does not easily
integrate into the observations made by analyzing neurogenic
functions in the DG. Rather, this experiment supports the idea of
ABC transporter-deficiency induced changes in the global
microenvironment of the brain. Furthermore, this altered
microenvironment could lead to the observed functional changes
in neurogenesis and even behavior.
While our mRNA expression analyses confirmed that all ABC
transporters investigated are expressed in NSPCs (except the
murine ABCB1 subtype ‘‘a’’), we also found evidence of possible
co-regulation of the expression levels of specific ABC transporters.
While the lack of ABCB1b expression augmented both ABCG2
and ABCC1 expression, in contrast, the loss of ABCG2 only had
a small lowering effect on ABCB1b expression, and deficiency of
Figure 7. ABC transporter-deficiency influences cortical architecture of layers I and VI while neuronal density is not altered. Paraffin-
embedded brain sections (A) were labeled with an antibody against NeuN, digitized, and the NeuN+ area was computer-assisted determined relative
to the cortical area to quantify the neuronal density of the cortex (B). The thickness of the cortical layers I, II–IV (combined), V and VI were measured
(A) and analyzed (C). The loss of ABCB1 expression significantly decreased the thickness of layer I (212%) while loss of ABCC1 only affected the
thickness of layer VI (+15%) Scale bars: 500 mm (A); Error bars: SEM, *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0035613.g007
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previous studies have not found regulatory mechanisms between
ABC transporter expression by analyzing whole brain homo-
genates [51,52], we show NSPC-specific regulatory mechanisms in
ABC transporter mRNA expression for the first time. It is
conceivable that these regulatory effects account for the altered
proliferation capacity in ABCG2
0/0 strains due to altered ABC
transporter expression profiles, increasing the cells’ capability to
cope with the cell culture environment. These cell-intrinsic effects
are so specific to environmental parameters of the in vitro situation
that this effect may be simply overwhelmed by the far-ranging
effects of altered brain homeostasis due to ABC transporter-
deficiency, leading to the effects observed in vivo.
The CCI model impairs the relatively isolated (privileged) state
of the brain by disrupting the blood-brain barrier. Following
trauma, metabolites from the bloodstream can directly access and
influence the previously protected stem cell pools. The excretion
functions of ABC transporters are also highly taxed to maintain
Figure 8. Lack of ABCB1 or ABCC1 expression leads to impaired exploratory activity. The diagrams show Y-maze-related parameters.
Plotting the animals’ course in the Y-maze, the running distance reveals a significant decrease in ABCB1- (213%) and ABCC1- (217%) deficient
animals (A), while this parameter was only slightly, non-significantly decreased in ABCG2-deficient mice. The same behavioral pattern was detected
for exploratory activity as assessed by the arm entries (ABCB1
0/0 216%; ABCC1
0/0 223%) (B). Error bar: SEM, *p,0.05.
doi:10.1371/journal.pone.0035613.g008
Figure 9. ABC transporter deficiency promotes anxiety. The diagrams show parameters assessed via the elevated plus maze. Mice deficient for
ABCB1 (244%) and ABCG2 (232%) showed a significantly decreased presence in the open arms (A). The time of residence in the closed
compartments was significantly increased in all ABC transporter-deficient mouse strains (ABCB1
0/0 +43%; ABCG2
0/0 +24%; ABCC1
0/0 +32%) (B).
Running speed (celerity) in the open arms was not changed in any of the ABC transporter-deficient mice (C). ABCB1 (223%) and ABCC1 (214%)
transporter-deficient mice showed significantly lower celerity values in the closed arms (D). Error bar: SEM, *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0035613.g009
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deficiency became most evident after CCI. Interestingly, ABCC1
has been discovered recently to play an important role in the
excretion of toxic Ab peptides in Alzheimer’s disease models via
the brain’s barriers [13]. In addition to its accumulation in
amyloid plaques, Ab monomers and oligomers have been
recognized to directly impair NSPC function [53]. Since the
present study shows that ABCC1 function also is important for
stem cell differentiation during disease states, it appears that ABC
transporters perform dual functions: i) clearing the brain of toxic
metabolites, and ii) preserving the microenvironment of the stem
cells in their niche. Both functions are necessary to protect against
age-related neurodegenerative processes.
InasmuchasthelackofABCtransportersaffectscellularfunction
in the brain, we hypothesized that behavioral integrity might be
compromised as well. Therefore, we assessed the effects of ABC
transporter deficiency on specific behaviors by using the Y-maze,
elevated plus-maze and light/dark box to assess overall activity,
exploratory drive and anxiety. We detected marked differences in
both activity and exploratory behavior in ABCB1- and ABCC1-
deficient mice. The decreased activity might partially reflect the
increasedanxietylevelsthatweredetectedintheelevatedplusmaze.
Notably, light/dark box tests revealed complex behavioral altera-
tions in those mice. While both ABCB1
0/0 and ABCC1
0/0 mice
show stronger avoidance of the light area (stress) than did controls,
ABCB1
0/0 mice displayed reduced fear/enhanced exploratory
behavior under non-stress conditions (dark area) and normal
Figure 10. Light/dark box experiments verified altered anxiety and exploratory behavior. Comparing the running distance of the animals
in the open field revealed no significant differences (A). However, the distance traveled by ABCB1-deficient mice (+64%) in the dark compartment (B)
was significantly increased compared to the controls. Also, the time in the dark compartment (C) was significantly increased in ABCB1
0/0 mice (+78%)
compared to controls. The mean number of transitions between the two compartments (D) was impaired in both ABCB1
0/0 (259%) and ABCC1
0/
0 (249%) mice. Comparing the rearing frequency in both compartments revealed a significant decrease for ABCC1
0/0 (267%) mice in the open field
(E), while the frequency was increased in the dark compartment (F) for ABCB1
0/0 (+71%) mice. Error bar: SEM, *,p0.05; **p,0.01.
doi:10.1371/journal.pone.0035613.g010
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0/0 mice
kept a normal phenotype under non-stress conditions, but in-
tensifiedanxietyinthelightarea(stress).Theseobservationsindicate
the need for further studies that will elucidate the complex
behavioral changes in these strains.
Deficiency in ABC transporter expression somehow seems to
minor effect brain ontogenesis in layer I and layer VI (layers with
least cellular density and mostly interconnecting axons and
dendrites) according to the altered cortical architecture in ABCB1
and ABCC1 transporter-deficient mice. Whether these changes
are primary or secondary due to changes in the cytoarchitecture of
other layers remains unclear since the total number of neurons is
not changed (Figure 7B). In addition to ontogenetic changes in
brain structure, it seems likely that ABC transporters alter the
biological milieu within the cells/brain. Steroids, for example, are
substrates for ABC transporters [54] that are able to alter
anxiogenic functions in specific sets of hippocampal neurons
[55]. Neurogenesis may contribute to certain behaviors, such as
enabling spatial learning in orientation tasks [56]. Because the
analyzed ABC transporter-deficient mice have an FVB/N
background with a known retinal degeneration leading to visual
deficits within the first 30 days of life [57,58], we were not able to
analyze the animals’ abilities in spatial orientation tasks based on
visual cues. Regarding performance on the other tasks, the visual
impairment should not be of consequence, due to the fact that
close-range orientation is based also on tactile stimuli [59]. The
mice are able to orient within the narrow corridors of the Y-maze
and easily recognize the open field and abyss surrounding the open
arms of the plus-maze, as shown in previous studies [60].
In summary, the diverse ABC transporter subfamily members
play important roles in physiologic and disease states of the brain.
Alteration of their function due to genetic predisposition (e.g.
promoter activity), slight structural variations (e.g. amino acid
exchanges), or transport activity (e.g. by drugs or metabolites) may
lead to early or prolonged effects on stem cell homing and
differentiation.ABCtransportersthushelptoregulatetwofunctions
that are important for maintaining the integrity of the brain during
aging and neurodegeneration – they export specific agents via the
brain’s barriers, and they also maintain the integrity and
functionality of the stem cell pool. The large number of ABC
transporter-modulating drugs that are used for the treatment of
chronic diseases suggests the feasibility of testing such agents as
potential modulators of neurodegeneration in acute and chronic
disorders.
Materials and Methods
Animals
FVB.129P2-Abcg2
tm1Ahs N7 (ABCG2
0/0), FVB.129P2-Abc-
b1a
tm1BorAbcb1b
tm1Bor N12 (ABCB1
0/0), and FVB.129P2-Abc-
c1a
tm1Bor N12 (ABCC1
0/0) mice were purchased from Taconic
Farms (Denmark) [28,61,62]. All mice were housed under a 12 h/
12 h light/dark cycle at 22uC with free access to food (SNIFF,
Germany) and water. All protocols involving the use of animals
were approved by the local authorities (LALLF M-V TSD 7221.3-
1.1-035/10 and LALLF M-V TSD 7221.3-1.1-024/11).
CCI-Surgery and BrdU injections
For each group (FVB controls, ABCB1
0/0, ABCG2
0/0,
ABCC1
0/0), 6 mice (3 males, 3 females) were used for controlled
cortical impact (CCI)-surgery at the age of 90 days. Animals were
anesthetized using a ketamine/xylazine mixture (1.9 mg/ml
ketamine; 0.5 mg/ml xylazine) at 20 ml per gram bodyweight.
Animals were placed in a stereotactic frame and a midline incision
was made to expose the skull. The skull was opened using a drill (ø
2 mm) at the position bregma 22.0 mm anterior and bregma
22.0 mm lateral. The impact device used for the CCI consisted of
a 1.2 mm diameter steel cannula with a deformed tip. The impact
device was driven 2.2 mm into the brain above the hippocampus.
After surgery, the wound was closed using suture clips [38,39]. To
analyze the proliferation capacities, a daily dose of 50 mg BrdU
per gram body weight was administered intraperitoneally for 7
consecutive days prior sacrifice.
Immunofluorescence and immunohistochemistry
Immunofluorescence. All animals were killed by cervical
dislocation and immediately transcardially perfused with 20 ml of
PBS followed by 20 ml of buffered, 4% paraformaldehyde (PFA)
as described previously [63]. The brains were extracted and post-
fixed in 4% PFA overnight and consecutively immersed in 15%
sucrose and 25% sucrose solutions, each step overnight. Whole
brains were mounted and frozen in cryo media (OCT Compound,
Tissue Tek). We chose a specific range of the hippocampus
(bregma 21.5 mm to bregma 22.2 mm) and cut (Leica CM3050
S) serial coronal sections (16 mm) within this 720 mm range from
whole brains and separated every third section alternately to one
of three containers for the different immunofluorescence staining
protocols. The entire number of sections was 45, which yielded
15 sections per group. For each protocol, 6 slices were taken
randomly from the respective pool and were stained
immunofluorescently. Cells were counted if within the
subgranular zone or no more than two cell diameters away [64]
in both hemispheres. The spacing of at least two sections between
the evaluated sections of each marker group maintains the key
consideration of unbiased stereological cell quantification that no
cell will occur in more than one section and therefore would not be
counted twice.
To reveal BrdU labeling, the brain sections were pre-incubated
in 1.5 M HCl for 30 min at 37uC to denature the DNA. Then, the
slices were washed three times in PBS before blocking for an hour
in 5% chicken serum in PBS with 0.5% Triton X-100. The
sections were incubated free-floating with the primary antibodies
anti-BrdU (1:600; Sigma clone BU-33), anti-Sox2 (1:400; Santa
Cruz clone Y-17), anti-DCX (1:400; Santa Cruz clone C-18) and
anti-calretinin (1:2000; Santa Cruz clone N-18) overnight in
blocking buffer at 4uC in the appropriate combinations of BrdU/
Sox2, BrdU/DCX and BrdU/calretinin. Incubation with fluores-
cence-labeled secondary antibodies (1:2000 anti-mouse Cy2;
1:2000 anti-goat Cy3; Dianova, Germany) was performed for
2 hours at room temperature after washing in PBS. The slices
were covered with DePex (Serva Electrophoresis, Germany) and
visualized using a Zeiss LSM 700 microscope. Cells were counted
if they were within the subgranular zone (SGZ) and excluded if
they were more than two cell diameters from the SGZ [64]. For
quantification of different cell populations, the reviewers remained
incognizant of the experimental groups. The labeled cells in the
dentate gyrus of each hemisphere were counted in 3 to 6 slices per
animal and marker combination. Six animals per group (3 males, 3
females) were analyzed.
Immunohistochemistry. Brains were harvested as
described above and post-fixed for at least 24 hours. The tissue
was paraffin-embedded, and 4 mm-thick coronal sections were cut.
Neurons were stained using the NeuN primary antibody (1:1000;
Millipore clone MAB377) on a Bond-Max
TM (Leica, Germany)
automated staining system and the Bond
TM Polymer Refine
Detection kit (Leica, Germany).
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Brain slices were digitized using a MIRAX Midi slide scanner
(Zeiss Microsystems, Germany). The scanned brain slices were
processed using a semi-automatic software macro programmed
within the AxioVision software package (Zeiss Microsystems,
Germany) to separate the stained neurons from the rest of the
cortical tissue. Specific regions of interest (ROI) were defined in
the cortex and used for further digital processing and area
normalization [41]. Furthermore, the NeuN stained sections were
used to determine the size of the cortical layers with the
AxioVision software package (Zeiss Microsystems, Germany).
Therefore, we measured the thickness of layer I, layer II-IV
(combined), layer V and layer VI according to Manuel et al. [42].
On each brain section two measurements were performed
approximately in the lateral parietal association cortex and the
barrel field of the primary somatosensory cortex. The average of
both measurements built the value for the according slice. The
average value for a distinct animal was calculated of the values of
its two associated hemispheres. For the analyses of cortical
cytoarchitecture 5–7 animals were analyzed for each strain.
Primary NSPC culture
Brains were extracted under sterile conditions from male
animals aged between 50 and 80 days. Harvested brains from 4
to 6 animals were transferred into ice-cold aCSF-media [65] to cut
2 mm thick coronal slices 6–8 mm behind the olfactory bulbs of
each brain. The tissue around the lateral ventricle was harvested
from the slices and was enzymatically digested for 10 min at 37uC
using a Trypsin/EDTA solution (GIBCO, Invitrogen Inc.). After
additional mechanical dissociation, cells were seeded in neuro-
sphere culture media (NeuroCultH, STEMCELL Technologies
Inc.) supplemented with EGF (20 ng/mL) and FGF (10 ng/mL)
(Peprotech Inc., USA) for 7 days until passaging after supplier’s
instructions. Cell lines were passaged at least four times before use
in proliferation or differentiation assays [66].
Proliferation assay. For measuring proliferation capacity,
cells (5610
4 cells/cm
2) were seeded for 24 h on Matrigel-coated
coverslips in 24-well plates under proliferation conditions. BrdU
(10 mM) was administered 1 h prior to fixation with
paraformaldehyde (4% in PBS). Labeling of incorporated BrdU
and cell nuclei using DAPI was performed according to the
description in the immunofluorescence section. Stained coverslips
were mounted in DePex (Serva Electrophoresis, Germany) on
glass slides and cells were visualized using a Zeiss laser scanning
microscope LSM 700. The relative proportion of BrdU
+ cell nuclei
against the overall number of DAPI
+ nuclei was used to compare
the proliferation capacity. The number of independent
experiments was n$11 for each strain.
Differentiation assay. Cells were seeded on Matrigel-coated
coverslips (1610
5 cells/cm
2) and were allowed to differentiate
under withdrawal of growth factors in differentiation media
(NeuroCultH Differentiation kit, STEMCELL Technologies Inc.).
After 3 days, cells were fixed for 10 minutes with
paraformaldehyde. The coverslips were incubated with a primary
antibody against Tuj1 (1:500, Covance) in blocking buffer at 4uC.
Incubation with fluorescence-labeled secondary antibody (1:2000
anti-mouse Cy3; Dianova, Germany) was performed for 2 hours
at room temperature after washing in PBS. The coverslips were
mounted in DePex on glass slides and were visualized using a Zeiss
LSM 700 microscope. The proportion of Tuj1
+ cells against the
whole number of DAPI
+ nuclei was used to compare the
proportion of newly differentiated neurons [53]. The number of
independent experiments was n$12 for each strain.
ABC transporter expression analysis using TaqManH
assays. Briefly, RNA was extracted from proliferating
neurosphere cultures at day three after passage using the Trizol
method. RNA was stored for later analysis at 280Cu in elution
buffer. 10 pg RNA were directly used for combined reverse
transcription (One-Step RT-PCR, Applied Biosystems) and
realtime quantitative PCR (TaqManH assays, Applied
Biosystems) in a single tube using a Rotorgene 6000 (Qiagen)
according to the supplier’s instructions. Multiplex reactions were
performed by simultaneously quantifying the FAM-labeled
internal control (GAPDH) and the VIC-labeled test sequence
(ABC transporters). Relative expression levels were calculated
using the DDCT method [67]. The following TaqManH assays
were purchased from Applied Biosystems: ABCB1a (cat#
Mm00440761_m1), ABCB1b (cat# Mm00440736_m1). ABCG2
(cat# Mm00496364_m1), ABCC1 (cat# Mm00456156_m1) and
GAPDH (cat# Mm99999915_g1). The number of analyzed
NSPC RNA samples is n=3 for each group.
Statistics
For quantification of different cell populations in stained brain
slices or cell culture, the reviewers remained incognizant of the
experimental groups. For all quantifications, statistical significance
(p#0.05) was determined using unpaired t-tests with Welch’s
correction (Graph Pad Prism 5).
Behavioral tests
Y-maze. Mice were tested in random order in a symmetrical
Y-shaped maze (TSE Systems). The dimensions of each arm were
325 mm (length), 85 mm (width) and 150 mm (height). Mice were
put into the middle of the maze and were allowed to move freely
throughout the maze. Their movement path was recorded with
a camera during the test duration of 5 min and analyzed with the
VideoMot software package (TSE Systems). The following
parameters were assessed: running distance, number of arm
entries, and the percentage of alternation [68]. At least 10 animals
per group were investigated.
Elevated Plus-Maze. Mice were tested randomly in an
elevated Plus-maze (TSE Systems). The dimensions of the arms
were: length 300 mm and width 50 mm; the maze was elevated
50 cm above the ground. Two opposing arms were either open or
enclosed by a wall of 150 mm height. To start, the mice were
placed in the center of the maze and allowed to move freely
throughout the entire maze. The path was recorded with a camera
during the test duration of 5 min and analyzed with the VideoMot
software package (TSE Systems). The following parameters were
assessed: number of closed arm entries, open arm entries, the
mouse’s speed in each compartment, the time spent in each of the
arms, and the time spent in the central area [69]. At least 9
animals per group were investigated.
Light/Dark box test. Mice were tested randomly in a Light/
Dark-Box (TSE Systems). The maze setup consisted of a box
(500 mm6500 mm6400 mm) that is divided into a darkened (1/
3
rd) and an illuminated compartment (2/3
rd, illuminated at
,400 Lux) connected by a door (60 mm660 mm). The mice
were set in the middle of the illuminated compartment facing away
from the door and were allowed to move freely within the two
compartments of the maze for 5 min. The course of the animal’s
movement was recorded using an infrared camera and infrared
light transilluminating the whole maze from below. The software
package VideoMot (TSE Systems) was used to analyze parameters
such as duration of stay per compartment, distance travelled per
compartment, transitions between compartments, and number of
ABC Transporters in Neurogenesis
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were investigated.
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